Close X
Saturday, November 16, 2024
ADVT 
National

Rob Ford Publicly Addresses Decision To Enter Rehab, Says Only He Made Decision

Darpan News Desk Darpan, 06 Sep, 2014 10:49 PM
    TORONTO - Rob Ford says the decision to enter rehab this year was his and his alone.
     
    The Toronto mayor brought up his decision to enter an Ontario rehab facility during a speech to at a business conference in Toronto on Saturday.
     
    In the speech to the National Franchise and Business Opportunities Show, Ford said he wished he did it years ago.
     
    He likened his struggles with addiction to a battle with "the man in the mirror" and that he finally said "enough is enough" before deciding to seek treatment.
     
    Ford says that he was the only person who could make the decision to seek treatment and he did so alone.
     
    Ford entered the Greenestone residential addiction treatment centre in late May after being confronted with reports of a video showing him allegedly smoking crack cocaine.
     
    Ford was in the rehab facility for two months and says he has since dealt with his substance abuse issues.
     
    He said the decision to enter rehab "just hit home" and that he looked at himself and said "that's it," before entering the facility.
     
    "Every time he kept beating me," Ford said of his reflection in the mirror. "I said 'you know what? Enough’s enough. I've got to put everything aside or else one day I'm not going to be able to see that guy anymore."
     
    Ford, who is in the midst of a re-election campaign, has admitted to smoking crack cocaine and being in a "drunken stupor." (AM640)

    MORE National ARTICLES

    Tekmira in talks about using experimental Ebola drug in infected patients

    Tekmira in talks about using experimental Ebola drug in infected patients
    VANCOUVER - Tekmira Pharmaceuticals Corp. (TSX:TKM) is in discussions about making its experimental Ebola drug available to infected patients, but says there is no guarantee the treatment can be used to help quell the outbreak in West Africa.

    Tekmira in talks about using experimental Ebola drug in infected patients

    Vancouver police officer used too much force during traffic stop: watchdog

    Vancouver police officer used too much force during traffic stop: watchdog
    A Vancouver police officer used excessive and unnecessary force when he punched a driver three times during a traffic stop in 2012, said a ruling by B.C.'s police watchdog.

    Vancouver police officer used too much force during traffic stop: watchdog

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto
    A Calgary company is looking to boost the profile of the world's newest, and most controversial, currency with the launch of six more teller machines in Toronto that deal in the virtual currency Bitcoin.

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto

    White House talking to Canada, others about aiding Iraqi refugees

    White House talking to Canada, others about aiding Iraqi refugees
    The United States is considering a multinational mission to whisk displaced people to safety in Iraq and it appears there may be a supporting role for Canada.

    White House talking to Canada, others about aiding Iraqi refugees

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful
    A special prosecutor has approved polygamy charges against the two leaders of an isolated religious sect in southeastern British Columbia.

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful

    Ebola drug developer Tekmira's net loss widens during second quarter

    Ebola drug developer Tekmira's net loss widens during second quarter
    Tekmira Pharmaceuticals Corp. (TSX:TKM) says it's in talks with governments and non-governmental organizations in various countries about the potential use of its experimental Ebola drug in infected patients.

    Ebola drug developer Tekmira's net loss widens during second quarter